Photronics Reports Fourth Quarter Fiscal 2017 Results
- Fourth quarter fiscal 2017 revenue was
$121.0 million , up 8% sequentially and 13% year-over-year - Net income attributable to
Photronics, Inc. shareholders was$5.4 million ($0.08 per diluted share) - Capital expenditures of
$53 million led to cash of$308 million at year end; balance sheet remains strong while funding strategic growth initiatives - First quarter fiscal 2018 guidance: revenue between
$110 and$118 million with diluted EPS between$0.02 and$0.09
Fourth quarter revenue was
Net income attributable to
"Revenue improved this quarter on the strength of high-end mask sales, particularly in IC where high-end memory continued the positive trend of the last four quarters, and high-end logic advanced on growing
Full Year Results
Full year revenue in fiscal 2017 was
Full year net income attributable to
First Quarter 2018 Guidance
Kirlin continued, "For fiscal 2018 first quarter, underlying high-end IC demand drivers still appear healthy, potentially tempered by anticipated seasonal softness. We expect high-end FPD demand to remain flat. Our cash balance will likely decrease during the quarter as we ramp up investments for the
Conference Call
A conference call to discuss these results is scheduled for
Non-GAAP Financial Measures
Non-GAAP net income attributable to
- Non-recurring tax benefit in fiscal 2016 related to the recognition of certain tax benefits in
Taiwan that were determined to be realizable in filings for future tax periods - Non-recurring net gain on sale of investment in fiscal 2016
- Interest expense, income tax expense/(benefit), depreciation and amortization, and other items are added to GAAP net income to derive non-GAAP EBITDA
About
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements made by or on behalf of
|
|||||||||||||||||||||
Condensed Consolidated Statements of Income | |||||||||||||||||||||
(in thousands, except per share amounts) | |||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||
Three Months Ended | Year Ended | ||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||
2017 | 2017 | 2016 | 2017 | 2016 | |||||||||||||||||
Revenue | $ | 120,971 | $ | 111,579 | $ | 107,368 | $ | 450,678 | $ | 483,456 | |||||||||||
Cost of goods sold | (94,529 | ) | (89,862 | ) | (86,835 | ) | (359,363 | ) | (364,750 | ) | |||||||||||
Gross profit | 26,442 | 21,717 | 20,533 | 91,315 | 118,706 | ||||||||||||||||
Operating Expenses: | |||||||||||||||||||||
Selling, general and administrative | (10,182 | ) | (11,639 | ) | (10,191 | ) | (43,585 | ) | (44,577 | ) | |||||||||||
Research and development | (3,838 | ) | (4,812 | ) | (5,041 | ) | (15,862 | ) | (21,654 | ) | |||||||||||
Total Operating Expenses | (14,020 | ) | (16,451 | ) | (15,232 | ) | (59,447 | ) | (66,231 | ) | |||||||||||
Operating income | 12,422 | 5,266 | 5,301 | 31,868 | 52,475 | ||||||||||||||||
Gain on sale of investment | - | - | - | - | 8,940 | ||||||||||||||||
Other income (expense), net | 536 | (134 | ) | (69 | ) | (5,303 | ) | (941 | ) | ||||||||||||
Income before income taxes | 12,958 | 5,132 | 5,232 | 26,565 | 60,474 | ||||||||||||||||
Income tax (provision) benefit | (2,462 | ) | (333 | ) | 1,337 | (5,276 | ) | (4,798 | ) | ||||||||||||
Net income | 10,496 | 4,799 | 6,569 | 21,289 | 55,676 | ||||||||||||||||
Net income attributable to noncontrolling interests | (5,110 | ) | (798 | ) | (1,313 | ) | (8,159 | ) | (9,476 | ) | |||||||||||
Net income attributable to |
$ | 5,386 | $ | 4,001 | $ | 5,256 | $ | 13,130 | $ | 46,200 | |||||||||||
Earnings per share: | |||||||||||||||||||||
Basic | $ | 0.08 | $ | 0.06 | $ | 0.08 | $ | 0.19 | $ | 0.68 | |||||||||||
Diluted | $ | 0.08 | $ | 0.06 | $ | 0.08 | $ | 0.19 | $ | 0.64 | |||||||||||
Weighted-average number of common shares outstanding: | |||||||||||||||||||||
Basic | 68,615 | 68,525 | 68,025 | 68,436 | 67,539 | ||||||||||||||||
Diluted | 69,218 | 69,380 | 68,906 | 69,288 | 76,354 |
|
|||||||
Condensed Consolidated Balance Sheets | |||||||
(in thousands) | |||||||
(Unaudited) | |||||||
|
|
||||||
2017 | 2016 | ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 308,021 | $ | 314,074 | |||
Accounts receivable | 105,320 | 92,636 | |||||
Inventories | 23,703 | 22,081 | |||||
Other current assets | 12,080 | 12,795 | |||||
Total current assets | 449,124 | 441,586 | |||||
Property, plant and equipment, net | 535,197 | 506,434 | |||||
Intangible assets, net | 17,122 | 19,854 | |||||
Other assets | 19,351 | 20,114 | |||||
Total assets | $ | 1,020,794 | $ | 987,988 | |||
Liabilities and Equity | |||||||
Current liabilities: | |||||||
Current portion of long-term borrowings | $ | 4,639 | $ | 5,428 | |||
Accounts payable and accrued liabilities | 77,137 | 75,889 | |||||
Total current liabilities | 81,776 | 81,317 | |||||
Long-term borrowings | 57,337 | 61,860 | |||||
Other liabilities | 16,386 | 19,337 | |||||
744,564 | 710,363 | ||||||
Noncontrolling interests | 120,731 | 115,111 | |||||
Total equity | 865,295 | 825,474 | |||||
Total liabilities and equity | $ | 1,020,794 | $ | 987,988 |
|
||||||||||
Condensed Consolidated Statements of Cash Flows | ||||||||||
(in thousands) | ||||||||||
(Unaudited) | ||||||||||
Year Ended | ||||||||||
|
|
|||||||||
2017 | 2016 | |||||||||
Cash flows from operating activities: | ||||||||||
Net income | $ | 21,289 | $ | 55,676 | ||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||
Depreciation and amortization | 86,573 | 82,406 | ||||||||
Gain on sale of investment | - | (8,940 | ) | |||||||
Changes in assets, liabilities and other | (11,029 | ) | (7,005 | ) | ||||||
Net cash provided by operating activities | 96,833 | 122,137 | ||||||||
Cash flows from investing activities: | ||||||||||
Purchases of property, plant and equipment | (91,965 | ) | (50,147 | ) | ||||||
Acquisition of Business | (5,400 | ) | - | |||||||
Proceeds from sale of investments | 167 | 101,853 | ||||||||
Other | (868 | ) | 584 | |||||||
Net cash (used in) provided by investing activities | (98,066 | ) | 52,290 | |||||||
Cash flows from financing activities: | ||||||||||
Repayments of long-term borrowings | (5,428 | ) | (57,609 | ) | ||||||
Payments to noncontrolling interests | (8,298 | ) | (12,856 | ) | ||||||
Proceeds from share-based arrangements | 2,830 | 3,463 | ||||||||
Other | (32 | ) | (20 | ) | ||||||
Net cash used in financing activities | (10,928 | ) | (67,022 | ) | ||||||
Effect of exchange rate changes on cash | 6,108 | 802 | ||||||||
Net (decrease) increase in cash and cash equivalents | (6,053 | ) | 108,207 | |||||||
Cash and cash equivalents, beginning of period | 314,074 | 205,867 | ||||||||
Cash and cash equivalents, end of period | $ | 308,021 | $ | 314,074 |
|
|||||||||||||||||
Non-GAAP Financial Measures | |||||||||||||||||
Reconciliation of GAAP to Non-GAAP Financial Information | |||||||||||||||||
(in thousands, except per share data) | |||||||||||||||||
(Unaudited) | |||||||||||||||||
Three Months Ended | Year Ended | ||||||||||||||||
|
|
|
|
|
|||||||||||||
2017 | 2017 | 2016 | 2017 | 2016 | |||||||||||||
Reconciliation of GAAP to Non-GAAP Net Income | |||||||||||||||||
Attributable to |
|||||||||||||||||
GAAP net income attributable to |
$ | 5,386 | $ | 4,001 | $ | 5,256 | $ | 13,130 | $ | 46,200 | |||||||
Income tax benefit (a) | - | - | (1,834 | ) | - | (4,838 | ) | ||||||||||
Gain on sale of investment, net of tax (b) | - | - | - | - | (8,753 | ) | |||||||||||
Non-GAAP net income attributable to |
$ | 5,386 | $ | 4,001 | $ | 3,422 | $ | 13,130 | $ | 32,609 | |||||||
Weighted average number of diluted shares outstanding | |||||||||||||||||
GAAP | 69,218 | 69,380 | 68,906 | 69,288 | 76,354 | ||||||||||||
Non-GAAP | 69,218 | 69,380 | 68,906 | 69,288 | 76,354 | ||||||||||||
Net income per diluted share | |||||||||||||||||
GAAP | $ | 0.08 | $ | 0.06 | $ | 0.08 | $ | 0.19 | $ | 0.64 | |||||||
Non-GAAP | $ | 0.08 | $ | 0.06 | $ | 0.05 | $ | 0.19 | $ | 0.47 | |||||||
Reconciliation of GAAP Net Income to Non-GAAP EBITDA | |||||||||||||||||
GAAP Net Income (c) | $ | 10,496 | $ | 4,799 | $ | 6,569 | $ | 21,289 | $ | 55,676 | |||||||
Interest expense | 578 | 550 | 616 | 2,235 | 3,366 | ||||||||||||
Income tax expense | 2,462 | 333 | (1,337 | ) | 5,276 | 4,798 | |||||||||||
Depreciation and amortization | 22,492 | 21,840 | 22,304 | 86,573 | 82,406 | ||||||||||||
Other items (d) | 785 | 984 | 980 | 3,627 | 3,828 | ||||||||||||
Non-GAAP EBITDA | $ | 36,813 | $ | 28,506 | $ | 29,132 | $ | 119,000 | $ | 150,074 | |||||||
Notes: | |
(a) | Represents tax benefit primarily related to the recognition of prior period tax benefits and other tax positions no longer deemed necessary in |
(b) | Represents gain on sale of investment in a foreign entity |
(c) | Includes net income attributable to noncontrolling interests, and in 2016 includes gain on sale of investment in a foreign entity |
(d) | Consists of stock compensation expense |
For Further Information:
Director, Investor Relations
(203) 740-5610
tdewar@photronics.com
Source:
News Provided by Acquire Media